VADS
ICING ORL
A Phase II Trial Assessing Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-ß and PD-L1, in a Pre-operative Setting for Resectable and Untreated Head and Neck Squamous Cell Carcinoma
Paris
CHRISTOPHE LE TOURNEAU, CHRISTOPHE LE TOURNEAU